You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Valganciclovir Therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Congenital Cytomegalovirus Infection Trial in United States (Valganciclovir)

Active, not recruiting
  • Congenital Cytomegalovirus Infection
  • Birmingham, Alabama
  • +8 more
Aug 18, 2022

Kaposi Sarcoma, Human Immunodeficiency Virus, Immune Reconstitution Syndrome Trial in Mexico city (Valganciclovir,

Completed
Has Results
  • Kaposi Sarcoma
  • +2 more
  • Mexico city, Mexico
    Instituto Nacional de Cancerologia
Nov 23, 2021

Glioblastoma Multiforme Trial in Solna (Valganciclovir Tablets, Temozolomide 120 mg, Radiotherapy 60 Gy)

Recruiting
  • Glioblastoma Multiforme
  • Valganciclovir Tablets
  • +3 more
  • Solna, Stockholm, Sweden
    SE01 Karolinska University Hospital
Sep 3, 2021

Congenital Cytomegaloviral (CMV) Disease Trial in United States (CMV Cytotoxic T-Lymphocytes, Anti-viral Therapy)

Recruiting
  • Congenital Cytomegaloviral (CMV) Disease
  • CMV Cytotoxic T-Lymphocytes
  • Anti-viral Therapy
  • Saint Louis, Missouri
  • +3 more
Oct 24, 2022

Cytomegalovirus Disease, Kidney Transplant Infection Trial in Los Angeles, Aurora, New Haven (Brincidofovir, Valganciclovir)

Terminated
Has Results
  • Cytomegalovirus Disease
  • Kidney Transplant Infection
  • Los Angeles, California
  • +2 more
Jun 27, 2021

Cytomegalovirus Infection Trial in United Kingdom, United States (Placebo, Valganciclovir)

Completed
Has Results
  • Cytomegalovirus Infection
  • Birmingham, Alabama
  • +17 more
May 6, 2021

Cytomegalovirus Infection Trial in United States (Valganciclovir)

Completed
Has Results
  • Cytomegalovirus Infection
  • Los Angeles, California
  • +5 more
Jul 29, 2021

Congenital Cytomegalovirus Infection Trial (Letermovir)

Not yet recruiting
  • Congenital Cytomegalovirus Infection
  • (no location specified)
Nov 1, 2023

Cytomegalovirus Infections, Transplant-Related Disorder Trial in Philadelphia (Letermovir 480 MG [Prevymis])

Not yet recruiting
  • Cytomegalovirus Infections
  • Transplant-Related Disorder
  • Letermovir 480 MG [Prevymis]
  • Philadelphia, Pennsylvania
    Penn Medicine at the University of Pennsylvania
Sep 27, 2023

Cytomegalovirus Infections, HIV Trial in Puerto Rico, United States (Valganciclovir)

Completed
  • Cytomegalovirus Infections
  • HIV Infections
  • Birmingham, Alabama
  • +56 more
Oct 28, 2021

Glioblastoma Multiforme, Cytomegalovirus Infection Trial in Solna, Umea, Uppsala (Valganciclovir (Valcyte), Placebo)

Completed
  • Glioblastoma Multiforme
  • Cytomegalovirus Infection
  • Valganciclovir (Valcyte)
  • Placebo
  • Solna, Stockholm, Sweden
  • +2 more
Feb 25, 2021

Chronic Fatigue Syndrome Trial in Stanford (valganciclovir)

Completed
  • Chronic Fatigue Syndrome
  • Stanford, California
    Stanford University Medical Center
May 23, 2022

Infections, Cytomegalovirus Trial in Cordoba (Letermovir 240 mg Oral Tablet)

Not yet recruiting
  • Infections, Cytomegalovirus
  • Letermovir 240 mg Oral Tablet
  • Cordoba, Córdoba, Spain
    Hospital Universitario Reina Sofia
Sep 25, 2023

Cmv Congenital, CMV, Congenital Cmv Trial in United States (Valganciclovir, Simple Syrup)

Active, not recruiting
  • Cmv Congenital
  • +4 more
  • Palo Alto, California
  • +29 more
Feb 22, 2022

Cytomegalovirus Infections Trial in Austria, Germany (Valganciclovir CMV Prophylaxis, Valganciclovir (Pre-emptive CMV Therapy),

Completed
Has Results
  • Cytomegalovirus Infections
  • Valganciclovir CMV Prophylaxis
  • +2 more
  • Innsbruck, Austria
  • +23 more
Feb 26, 2020

Cytomegalovirus Anterior Uveitis Trial in San Francisco (Valganciclovir Hydrochloride, Ganciclovir Sodium, Placebo Oral Tablet)

Recruiting
  • Cytomegalovirus Anterior Uveitis
  • Valganciclovir Hydrochloride
  • +3 more
  • San Francisco, California
    Proctor Foundation, UCSF
Jul 1, 2022

Lymphoproliferative Disorder, HHV-8, Malignancy Trial run by the National Cancer Institute (NCI) (Etoposide, Interferon-alpha,

Active, not recruiting
  • Lymphoproliferative Disorder
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022

Liver Transplantation Trial in San Francisco, Chicago, Rochester (biological, drug, procedure)

Terminated
Has Results
  • Liver Transplantation
  • Anti-Thymocyte Globulin - Rabbit
  • +12 more
  • San Francisco, California
  • +2 more
Sep 2, 2020

Lung Transplant, CMV Trial in Pittsburgh (Letermovir, Valganciclovir)

Recruiting
  • Lung Transplant
  • CMV
  • Pittsburgh, Pennsylvania
  • +1 more
May 16, 2022

Kidney Transplant Infection Trial in Córdoba (New profilaxis, Profilaxis recommended)

Completed
  • Kidney Transplant Infection
  • New profilaxis
  • Profilaxis recommended
  • Córdoba, Spain
    Hosìtal Universitario Reina Sofia
Jan 29, 2021

Malignant Glioma of Brain, Astrocytoma, Malignant Astrocytoma Trial in Detroit (Ad5-yCD/mutTKSR39rep-ADP adenovirus and

Recruiting
  • Malignant Glioma of Brain
  • +8 more
  • Ad5-yCD/mutTKSR39rep-ADP adenovirus and fractionated stereotactic radiosurgery (fSRS)
  • Detroit, Michigan
    Henry Ford Health System
Jan 9, 2023

Cytomegalovirus Infection Outcomes Among Solid Organ Transplant

Not yet recruiting
  • Cytomegalovirus (CMV)
    • (no location specified)
    Oct 18, 2022

    End Stage Renal Disease Trial in Zurich (Kidney and hematopoietic stem cell transplantation, hematopoietic stem cell)

    Recruiting
    • End Stage Renal Disease
    • Kidney and hematopoietic stem cell transplantation
    • hematopoietic stem cell
    • Zurich, Switzerland
      University Hospital Zurich
    Mar 31, 2022

    Cytomegalovirus Infection Outcomes Among Hematopoietic Stem Cell

    Not yet recruiting
    • Cytomegalovirus (CMV)
      • (no location specified)
      Oct 11, 2022

      Kidney Transplant; Complications, CMV Trial (Letermovir 480 mg once daily, Historical/Control)

      Not yet recruiting
      • Kidney Transplant; Complications
      • CMV
      • Letermovir 480 mg once daily
      • Historical/Control
      • (no location specified)
      Aug 14, 2023